new IV antibiotic, Merrem (meropenem)

Zeneca is promoting a new IV antibiotic, Merrem (meropenem).

Meropenem is the second carbapenem antibiotic to hit the market...after imipenem/cilastatin (Primaxin).

Both Merrem and Primaxin have similar antibacterial coverage...broad gram-positive and gram-negative aerobic and anaerobic coverage.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote